Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.
WSJ.com: What's News US, Wall Street Journal
Wed, 08/24/2016 - 6:58pm
Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.